Pod: Eric Topol’s Misdiagnosis

Being named as author on a bogus paper is just a symptom of a deeper problem

Pod: Eric Topol’s Misdiagnosis
APOLOGIES for any audio issues. Kent changed a setting on his Internet after our last episode, and didn’t realize it would compress things like this. We’ve adjusted the audio as best we could so it’s still easy on the ears, and settings have been reverted.

Today we take a deep dive into a fake paper involving Eric Topol, one of the most prominent names in what we have to call “mainstream medicine” today. We’re going to offer our second opinion on what we know to be his misdiagnosis of what should be done to cure this “problem.”

A clue to the real source of the problem is the only “real” thing about the paper — the DOI. CrossRef has failed to realize that the DOI is a brand asset being exploited across scientific publishing as a fake certification code. (Why display it? The DOI is metadata that can be hidden in a link? Because it’s a branding element hinting at certification.) Predatory publishers boast when they get a DOI. Pseudoscience grifters litter their citation lists with DOIs to make it appear as if certifying bodies have signed off on their claims. So, it’s no wonder that usage of DOIs is spiking as MAHA and other fake science grifts accelerate:

This points out a lack of serious governance of certification in general, even accidental certification via technological tools that can be made to look validating and certifying to those outside science.

We start with a side-quest into the papers offered to the Trump Administration by Joe Rogan to get an executive order about psychedelics rolling, to the benefit of political cronies in Texas, where Rogan lives.

Finally, we have our “Discoveries of the Week.”

Subscribe to our podcast

Music provided by Provoke the Truth — https://provokethetruth.net/ 



Pre-order Your Copy Today!

Subscribe to The Geyser

Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe